Connecting TDP-43 Pathology with Neuropathy

Trends Neurosci. 2021 Jun;44(6):424-440. doi: 10.1016/j.tins.2021.02.008. Epub 2021 Apr 5.

Abstract

Transactive response DNA-binding protein 43 kDa (TDP-43), a multifunctional nucleic acid-binding protein, is a primary component of insoluble aggregates associated with several devastating nervous system disorders; mutations in TARDBP, its encoding gene, are a cause of familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Here, we review established and emerging roles of TDP-43 and consider how its dysfunction impinges on RNA homeostasis in the nervous system, thereby contributing to neural degeneration. Notably, improper splicing of the axonal growth-associated factor STMN2 has recently been connected to TDP-43 dysfunction, providing a mechanistic link between TDP-43 proteinopathies and neuropathy. This review highlights how a deep understanding of the function of TDP-43 in the brain might be leveraged to develop new targeted therapies for several neurological disorders.

Keywords: RNA binding protein; SCG10; Stathmin2; amyotrophic lateral sclerosis (ALS); frontotemporal dementia (FTD); motor neuron disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amyotrophic Lateral Sclerosis* / genetics
  • Axons
  • DNA-Binding Proteins / genetics
  • Frontotemporal Dementia*
  • Humans
  • Mutation

Substances

  • DNA-Binding Proteins
  • TARDBP protein, human